Goldman Sachs Group INC Schedule 13G passive stakes

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have updated their beneficial ownership filing for Lafayette Digital Acquisition Corp. I, reporting shared voting and dispositive power over 230,205 Class A ordinary shares.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 1.2% of Iris Acquisition Corp II's Class A ordinary shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a beneficial ownership of 9.4% in IREN LIMITED's ordinary shares.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amendment to their Schedule 13G, reporting beneficial ownership of Hello Group Inc. American depositary shares.

The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of 4.9% of Harvard Ave Acquisition Corp's Class A ordinary shares.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 4.3% of Coreweave, Inc.'s Class A common stock as of June 30, 2026.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting their beneficial ownership of B&G Foods, Inc. common stock.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting 0.0% beneficial ownership of Enhanced Group Inc.'s Class A Ordinary Shares.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G regarding their beneficial ownership of Amicus Therapeutics, Inc. common stock.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 5.2% of People Incorporated's common stock as of June 30, 2026.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting 0.00% beneficial ownership of Cantaloupe, Inc. common stock as of June 30, 2026.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 4.5% of Charlton Aria Acquisition Corp's Class A ordinary shares as of June 30, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have updated their beneficial ownership filing for Karyopharm Therapeutics Inc., reporting a 6.3% stake.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 7.8% of Oceanhawk Acquisition Corp.'s Class A ordinary shares as of June 30, 2026.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 443,867 Class A ordinary shares of Lake Superior Acquisition Co.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of 676,022 shares, representing 4.8% of Graf Global Corp.'s Class A ordinary shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 5.8% of GenEdx Holdings Corp.'s Class A common stock as of June 30, 2026.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amendment to their Schedule 13G, reporting a change in beneficial ownership of D. Boral Arc Acquisition I Corp. Class A ordinary shares.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of Agilon Health, Inc. common stock.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting a 4.3% beneficial ownership of Class A ordinary shares in Agriculture & Natural Solutions Acquisition Corporation.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of 4.5% of Activate Energy Acquisition's Class A ordinary shares.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 3.0% of Abpro Holdings Inc.'s common stock.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of 0.1% of Brazil Potash Corp.'s common shares.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 4.9% of Cal Redwood Acquisition Corp's Class A Ordinary Shares.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amendment to their Schedule 13G, disclosing their beneficial ownership of Delek US Holdings, Inc. common stock.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have jointly filed a Schedule 13G, reporting beneficial ownership of 5.6% of Energy Transition Special Opportunities' Class A ordinary shares.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amendment to their Schedule 13G, updating their beneficial ownership information for Etsy, Inc.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 4.1% of Fact II Acquisition Corp's Class A ordinary shares as of June 30, 2026.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported beneficial ownership of 5.2% of HCM IV Acquisition Corp's Class A Ordinary Shares as of June 30, 2026.

Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a change in their beneficial ownership of Leggett & Platt, Inc. common stock.